Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 261: The reference date for census population count is:

A. 1st March (Correct Answer)
B. 1st July
C. 30th June
D. 1st January

Explanation: **Explanation:** In India, the **Census** is a decennial exercise conducted under the Census Act, 1948. The reference date is the specific point in time to which the census data refers, ensuring a "snapshot" of the population. **1. Why 1st March is Correct:** The official reference date for the Indian Census is **00:00 hours of 1st March** of the census year (e.g., 2001, 2011). For the states of Jammu & Kashmir, Himachal Pradesh, and Uttarakhand (hilly areas), the reference date is often 1st October of the preceding year due to snow-bound conditions, but for the national count, 1st March remains the standard. **2. Analysis of Incorrect Options:** * **1st July (Option B):** This is the reference date for calculating the **Mid-year Population**. In demography, the mid-year population is used as the denominator for calculating vital rates like Crude Birth Rate (CBR) and Crude Death Rate (CDR). * **30th June (Option C):** This is often confused with the mid-year point but is not the standard reference date for Indian demographic statistics. * **1st January (Option D):** This is the reference date used for the preparation of **Electoral Rolls** in India, not the national census. **High-Yield Clinical Pearls for NEET-PG:** * **Census Interval:** Conducted every 10 years (Decennial). * **Mid-year Population:** Always calculated as of **July 1st**. It is the most common denominator in epidemiology because it accounts for population turnover (births, deaths, and migration) throughout the year. * **De facto vs. De jure:** India uses an "Extended De Facto" method (counting people where they are found during the enumeration period, typically 3 weeks). * **First Census:** The first synchronous census in India was held in **1881**.

Question 262: BCG vaccination is given at birth to prevent future infection by M. tuberculosis. This intervention is a type of?

A. Primary prevention (Correct Answer)
B. Secondary prevention
C. Tertiary prevention
D. Primordial prevention

Explanation: ### Explanation **1. Why Primary Prevention is Correct:** Primary prevention aims to prevent the **onset of disease** by controlling risk factors or increasing resistance to a pathogen. It occurs in the **pre-pathogenesis phase** (before the disease process has started). Immunization, such as the BCG vaccine, is a classic example of **Specific Protection**, which is a mode of intervention under primary prevention. By administering BCG at birth, the body develops immunity against *M. tuberculosis*, thereby preventing the development of severe forms of tuberculosis (like TB meningitis or miliary TB). **2. Why Other Options are Incorrect:** * **Primordial Prevention:** This involves preventing the **emergence or establishment of risk factors** (e.g., discouraging children from starting smoking or promoting healthy eating to prevent obesity). Since the "risk factor" (the bacteria) already exists in the environment, BCG is primary, not primordial. * **Secondary Prevention:** This focuses on **early diagnosis and prompt treatment** (e.g., Sputum microscopy for TB, Pap smears for cervical cancer). It aims to halt disease progression and prevent complications after the disease process has begun. * **Tertiary Prevention:** This occurs in the **late pathogenesis phase** and focuses on **disability limitation and rehabilitation** (e.g., DOTS therapy to prevent relapse or physical therapy after a stroke). **3. NEET-PG High-Yield Pearls:** * **Modes of Intervention for Primary Prevention:** 1. Health Promotion (General) 2. Specific Protection (Vaccines, Chemoprophylaxis). * **BCG Vaccine:** It is a live attenuated vaccine (Danish 1331 strain). It is given **Intradermally** over the left deltoid. * **The "Rule of Thumb":** If the action is taken to keep a person healthy (Vaccines/Nutrition), it is **Primary**. If the action is taken because a person might be sick (Screening/Tests), it is **Secondary**.

Question 263: All of the following statements regarding case-control and cohort studies are true, except-

A. Case-control studies are chosen based on history of 'Exposure'
B. Cohort studies require a longer time frame than case-control studies
C. Cohort studies are suitable to investigate 'rare' diseases (Correct Answer)
D. Cohort studies yield information about more than one disease

Explanation: In epidemiology, the choice between study designs depends on the frequency of the outcome and the nature of the exposure. **Explanation of the Correct Answer (Option C):** Cohort studies are **not** suitable for investigating rare diseases. In a cohort study, you start with a group of exposed individuals and wait for the disease to develop. If a disease is rare (e.g., a specific rare cancer), you would need to follow an enormous number of people for a very long time to see even a few cases, making it inefficient and expensive. **Case-control studies** are the design of choice for rare diseases because they start with people who already have the disease (cases) and look backward. **Analysis of Incorrect Options:** * **Option A:** In case-control studies, subjects are selected based on the **outcome** (Disease), whereas in cohort studies, they are selected based on **exposure**. This statement is a common point of confusion; however, the question asks for the "false" statement. * **Option B:** Cohort studies are prospective (usually), requiring years of follow-up to observe the development of the disease. Case-control studies are retrospective and can be completed quickly using existing records. * **Option C:** This is the false statement. Cohort studies are ideal for **rare exposures** (e.g., a specific occupational chemical), not rare diseases. * **Option D:** Since cohort studies follow a group over time, researchers can observe the development of multiple different outcomes/diseases resulting from a single exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Rare Disease:** Use Case-Control Study. * **Rare Exposure:** Use Cohort Study. * **Incidence:** Can only be calculated directly from Cohort studies. * **Odds Ratio:** The measure of association for Case-Control. * **Relative Risk (RR) & Attributable Risk (AR):** The measures of association for Cohort studies.

Question 264: At a birthday party attended by 200 people, 55 people developed food poisoning. What is the attack rate?

A. 25%
B. 27.5% (Correct Answer)
C. 30%
D. 35%

Explanation: ### Explanation **1. Why Option B is Correct:** The **Attack Rate** is a specific type of incidence rate used during short-term outbreaks (like food poisoning). It measures the proportion of people in a defined population who become ill during a specific time period. The formula for Attack Rate is: $$\text{Attack Rate} = \frac{\text{Number of new cases}}{\text{Total population at risk}} \times 100$$ Plugging in the values from the question: * Number of new cases = 55 * Total population at risk = 200 * Calculation: $(55 / 200) \times 100 = \mathbf{27.5\%}$ **2. Why Other Options are Incorrect:** * **Option A (25%):** This would be the result if only 50 people were affected ($50/200$). * **Option C (30%):** This would require 60 people to be affected ($60/200$). * **Option D (35%):** This would require 70 people to be affected ($70/200$). These options are mathematically incorrect based on the data provided. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Nature of the Metric:** Despite its name, the Attack Rate is actually a **proportion**, not a true rate, because the time dimension is not explicitly in the denominator (it is expressed as a percentage). * **Secondary Attack Rate (SAR):** This measures the spread of a disease from a primary case to contacts within a closed group (e.g., a household). It is a key indicator of the **communicability** or infectiousness of an agent. * **Food-Specific Attack Rate:** Used to identify the "culprit" food item by comparing the attack rates among those who ate a specific dish versus those who did not. * **Primary Case vs. Index Case:** The first case to appear in a population is the *Primary Case*; the first case to come to the attention of the investigator is the *Index Case*.

Question 265: Total fertility rate is defined as:

A. The average number of children born to a woman over her lifetime. (Correct Answer)
B. The number of female children born to a woman over her lifetime.
C. The number of male children born to a woman over her lifetime.
D. The number of female children born to a married woman in the reproductive age group.

Explanation: **Explanation:** **Total Fertility Rate (TFR)** is a critical demographic indicator used to estimate the average number of children a woman would have if she were to pass through her reproductive years (15–49 years) experiencing the age-specific fertility rates of a given year. It is considered the best single indicator of fertility as it is independent of the age structure of the population. **Why Option A is Correct:** TFR represents the completed family size. It is calculated by summing the Age-Specific Fertility Rates (ASFR) for all ages in the reproductive period. If ASFR is calculated in 5-year age groups, the sum is multiplied by 5. **Why Other Options are Incorrect:** * **Option B:** This describes the **Gross Reproduction Rate (GRR)**. GRR specifically counts only female births, assuming no mortality before the end of the reproductive period. * **Option C:** There is no standard epidemiological term defined specifically by the number of male children born to a woman. * **Option D:** This is a distractor. While fertility is measured within the reproductive age group, TFR is not restricted to "married" women in global definitions, and it refers to total children, not just females. **High-Yield Clinical Pearls for NEET-PG:** * **Replacement Level Fertility:** The TFR at which a population exactly replaces itself from one generation to the next without migration. For most developed countries, it is **2.1**. * **Current Trend:** According to NFHS-5, India’s TFR has declined to **2.0**, which is below the replacement level. * **Net Reproduction Rate (NRR):** Unlike GRR, NRR accounts for the mortality of mothers. An **NRR of 1** is the demographic goal for population stabilization.

Question 266: The National Iron Plus Initiative is an example of which type of prevention?

A. Primordial prevention
B. Primary prevention (Correct Answer)
C. Secondary prevention
D. Tertiary prevention

Explanation: **Explanation:** The **National Iron Plus Initiative (NIPI)** is a strategic intervention aimed at preventing iron deficiency anemia across the life cycle. It is classified as **Primary Prevention** because it involves **Specific Protection**. 1. **Why Primary Prevention is Correct:** Primary prevention aims to prevent the onset of a disease by controlling causes and risk factors before the disease process begins. NIPI provides prophylactic Iron and Folic Acid (IFA) supplementation to asymptomatic individuals (children, adolescents, women of reproductive age, and pregnant/lactating women). Since the goal is to "protect" the population from developing anemia, it falls under the "Specific Protection" mode of primary prevention. 2. **Why other options are incorrect:** * **Primordial Prevention:** This focuses on preventing the emergence of risk factors (e.g., discouraging children from starting junk food habits). Since the risk factor (nutritional deficiency) already exists in the population, NIPI is not primordial. * **Secondary Prevention:** This involves early diagnosis and prompt treatment (e.g., screening for anemia using Hemoglobin levels and treating confirmed cases with therapeutic doses). NIPI’s core component is mass prophylaxis, not just screening. * **Tertiary Prevention:** This aims to reduce impairments and disabilities from established disease (e.g., blood transfusion for severe anemia or cardiac rehab). **High-Yield Clinical Pearls for NEET-PG:** * **Modes of Primary Prevention:** Health Promotion (e.g., nutrition education) and Specific Protection (e.g., Immunization, IFA supplementation, Chemoprophylaxis). * **NIPI Dosage (Adolescents 10-19 yrs):** 100 mg elemental Iron + 500 mcg Folic Acid weekly (WIFS). * **Pregnant Women:** 100 mg elemental Iron + 500 mcg Folic Acid daily for 180 days starting from the 4th month of pregnancy.

Question 267: Maximum power of destruction of a disease is measured by?

A. Survival rate
B. Case fatality rate (Correct Answer)
C. Specific death rate
D. Proportional mortality rate

Explanation: ### Explanation The **Case Fatality Rate (CFR)** is the most accurate measure of the **virulence** or the "killing power" of a disease. It represents the proportion of people diagnosed with a specific disease who die from it within a specified period. **Formula:** $\frac{\text{Total deaths from a disease}}{\text{Total number of cases of that disease}} \times 100$ #### Why Case Fatality Rate is Correct: CFR directly reflects the severity of a clinical condition. It measures the probability of death among those who have contracted the disease. A high CFR indicates a highly virulent pathogen or a disease with a high "power of destruction" (e.g., Rabies has a CFR of nearly 100%, whereas Common Cold has a CFR of 0%). #### Why Other Options are Incorrect: * **Survival Rate:** This is the complement of CFR. It measures the proportion of survivors (usually over 5 years in cancer epidemiology) and reflects the prognosis and efficacy of treatment rather than the "destructive power." * **Specific Death Rate:** This measures the number of deaths in a specific group (e.g., age-specific or cause-specific) relative to the **entire population** at risk, not just those who have the disease. It is used to identify high-risk groups in a community. * **Proportional Mortality Rate:** This measures the proportion of total deaths due to a specific cause (e.g., deaths from CVD / total deaths from all causes). It indicates the relative importance of a disease as a cause of death in a population but does not measure the disease's inherent virulence. #### High-Yield Pearls for NEET-PG: * **Virulence** is clinically measured by **Case Fatality Rate**. * **Infectivity** is measured by **Secondary Attack Rate**. * **Pathogenicity** is the ability to produce clinically apparent illness. * CFR is **not** a true rate but a **ratio** (expressed as a percentage) because the time element is often not explicitly defined in the denominator. * CFR is inversely related to the effectiveness of treatment.

Question 268: What determines the incubation period of a new disease?

A. Lead time
B. Generation time (Correct Answer)
C. Serial interval
D. Latent period

Explanation: **Explanation:** The **Generation Time** is the correct answer because it represents the interval between the receipt of infection by a host and the maximal infectivity of that host. In the context of descriptive epidemiology for a new or emerging disease, the generation time is the fundamental biological parameter that determines the speed of spread and, consequently, the **incubation period**. While the incubation period refers to the time from infection to the onset of clinical symptoms, the generation time tracks the biological life cycle of the pathogen within the host, effectively dictating the timeline for symptom manifestation. **Analysis of Incorrect Options:** * **Lead Time:** This is the period between early detection of a disease (usually via screening) and the time of usual clinical diagnosis. It is related to screening programs, not the natural history of infection. * **Serial Interval:** This is the time gap between the onset of primary cases and secondary cases. While it is often used as a proxy for generation time in field studies, it is a measure of transmission between individuals rather than a determinant of the disease's internal timeline. * **Latent Period:** This is the interval from infection to the onset of infectiousness. It may be shorter or longer than the incubation period, but it does not "determine" it; rather, it defines when a person becomes a source of infection. **High-Yield Clinical Pearls for NEET-PG:** * **Median Incubation Period:** Used to determine the most likely source of exposure in an outbreak. * **Quarantine Period:** Usually fixed at the **maximum incubation period** of a disease. * **Generation Time vs. Serial Interval:** If the Serial Interval is shorter than the Incubation Period, it implies **pre-symptomatic transmission** (e.g., COVID-19, Measles). * In a stable population, the generation time is roughly equal to the serial interval.

Question 269: Patients diagnosed with a Sexually Transmitted Disease (STD) are asked to name other individuals within their socio-sexual network. These named individuals are then screened for the disease. What is this process called?

A. Cluster testing (Correct Answer)
B. Mass screening
C. High-risk screening
D. None of the above

Explanation: **Explanation:** **1. Why Cluster Testing is Correct:** Cluster testing is a targeted epidemiological strategy used primarily in the control of Sexually Transmitted Diseases (STDs). In this process, an infected individual (the index case) is asked to identify members of their social or sexual network (the "cluster") who may have been exposed to the same source of infection or who may have been infected by the index case. These individuals are then traced and screened. Unlike standard contact tracing, which focuses strictly on direct sexual partners, cluster testing expands the scope to include social associates and peers within a high-risk network, making it a highly effective tool for identifying asymptomatic cases and "hotspots" of transmission. **2. Why Other Options are Incorrect:** * **Mass Screening:** This involves screening an entire population or a large, unselected group (e.g., screening all pregnant women for syphilis). It is not targeted based on individual networks. * **High-risk Screening:** While cluster testing is a form of high-risk screening, the term "High-risk screening" is broader and refers to screening groups based on specific behaviors or occupations (e.g., screening commercial sex workers or IV drug users) rather than individual network-based identification. **3. High-Yield Clinical Pearls for NEET-PG:** * **Contact Tracing vs. Cluster Testing:** Contact tracing identifies *direct* sexual partners; Cluster testing identifies the *wider network* (friends, social associates, and partners). * **Application:** Cluster testing is most useful in diseases with high social stigma or those concentrated in specific sub-populations (e.g., Syphilis, HIV). * **Yield:** It increases the "case-finding" yield compared to random or mass screening in low-prevalence areas.

Question 270: If the objective is to assess the incidence of tuberculosis infection in a community, what is the most appropriate methodology?

A. Identify all individuals with a positive tuberculin test.
B. Perform sputum examination of chest symptomatic individuals.
C. Identify new converters to the tuberculin test. (Correct Answer)
D. Screen all under-five children with a tuberculin test.

Explanation: ### Explanation **1. Why Option C is Correct:** The core concept here is the distinction between **Incidence** and **Prevalence**. Incidence refers to the number of *new cases* occurring in a defined population during a specific period. In the context of Tuberculosis (TB) infection, the **Tuberculin Skin Test (TST/Mantoux)** is the standard tool to detect infection. A "new converter" is an individual who previously tested negative but has now tested positive, signifying a recent infection. Therefore, monitoring the rate of tuberculin conversion is the most direct way to measure the **Annual Risk of Tuberculosis Infection (ARTI)**, which is the best indicator of the transmission trend in a community. **2. Why Other Options are Incorrect:** * **Option A:** Identifying all positive tuberculin tests measures **Prevalence**, not Incidence. It includes both old and new infections, making it impossible to determine when the infection occurred. * **Option B:** Sputum examination identifies **TB Disease** (active cases), not **TB Infection** (latent state). While it measures the incidence of infectious cases, it does not capture the broader incidence of infection in the general population. * **Option D:** While screening children (especially those without BCG scars) is often used to estimate ARTI, simply screening them once only provides a "point prevalence" of infection. To measure incidence, you must specifically track the *change* from negative to positive status. **3. NEET-PG High-Yield Pearls:** * **ARTI (Annual Risk of TB Infection):** It is the most sensitive indicator for evaluating the TB problem and the impact of control measures in a community. * **1% ARTI** roughly correlates to an incidence of **50-60 new smear-positive cases** per 100,000 population per year. * **Infection vs. Disease:** TST/IGRA measures *Infection*; Sputum/Culture/CBNAAT measures *Disease*. * **Incidence** is always measured through a **Longitudinal (Cohort) Study**, which is what tracking "converters" represents.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free